|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
5.330 +0.220 (+4.305%) | 2025/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/09 RMB(K¥) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | |
| Turnover | 16,697,093 | 16.978% | 14,273,724 | 12,956,000 | 11,500,569 | 9,357,715 |
| Cost of Sales | (12,513,115) | 16.510% | (10,739,959) | (10,087,332) | (9,199,913) | (7,486,940) |
| Gross Profit | 4,183,978 | 18.400% | 3,533,765 | 2,868,668 | 2,300,656 | 1,870,775 |
| 2025/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/09 RMB(K¥) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (16,507) | -23.048% | (21,451) | (8,191) | 385 | (24,385) | |
| Profit / (Loss) before Taxation | 1,429,252 | 74.072% | 821,069 | 481,271 | 173,975 | (229,862) | |
| Taxation | (162,839) | 213.026% | (52,021) | (36,128) | (10,466) | (1,706) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 216 | -- | (95) | 748 | (1,315) | (203) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,266,629 | 64.721% | 768,953 | 445,891 | 162,194 | (231,771) | |
| 2025/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/09 RMB(K¥) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | |
| Net Finance Costs / (Income) | (231,242) | 1.626% | (227,543) | (201,856) | (143,141) | (85,721) |
| Depreciation & Amortisation | 23,573 | -10.759% | 26,415 | 25,225 | 35,897 | 23,059 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2024/09 | 2023/09 | 2022/09 | 2021/09 | |
| EPS (cts) | 7.860 | 64.092% | 4.790 | 3.300 | 1.200 | -1.720 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.089 | -- | 0.949 | 1.189 | -- | 1.043 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,266,629 |
| %Change | 64.721% |
| EPS / (LPS) | RMB 0.079 |
| NBV Per Share (¥) | RMB 1.089 |